| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $1.93B | -0.6% |
| Cost of Revenue | $1.19B | +0.8% |
| Gross Profit | $739.8M | -2.8% |
| R&D Expense | $159.8M | +10.1% |
| SG&A Expense | $81.0M | +14.1% |
| Operating Income | $499.0M | -8.4% |
| Pre-tax Income | $423.8M | -12.9% |
| Income Tax | $73.9M | -6.1% |
| Net Income | $350.0M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $126.3M | +10.0% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $169.1M | +0.8% |
| Inventory | $462.0M | -37.3% |
| Current Assets | $916.0M | -21.5% |
| Total Assets | $1.15B | -17.9% |
| Current Liabilities | $284.8M | -19.1% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $541.5M | +472.4% |
| Capital Expenditures | $12.0M | -42.8% |
| Investing Cash Flow | -$12.0M | +42.8% |
| Financing Cash Flow | -$518.0M | -457.3% |
| Free Cash Flow | $529.5M | +418.3% |
| -14.1% |
| EPS (Basic) | $5.79 | -14.2% |
| EPS (Diluted) | $5.79 | -14.1% |
| Long-term Debt |
| $708.1M |
| -34.5% |
| Total Liabilities | $1.06B | -30.4% |
| Stockholders' Equity | $95.1M | +182.1% |